British drugmaker AstraZeneca has started early testing of an antibody-based treatment for the prevention and treatment of COVID-19, the company said on Tuesday.
Meanwhile, there is also a promising development in the company’s efforts to create a vaccine against the coronavirus.could be put before regulators this year if scientists are able to gather enough data, Andrew Pollard, the director of the Oxford Vaccine Group, said on Tuesday.
“It is just possible that if the cases accrue rapidly in the clinical trials, that we could have that data before regulators this year, and then there would be a process that they go through in order to make a full assessment of the data,” Pollard told BBC Radio.in July when it produced an immune response, making it one of the leading candidates in the race to produce a COVID-19 vaccine.
Though vaccines are at the heart of the long-term fight against the pandemic, alternative treatments are also being advanced.to treat COVID-19, a treatment that more than 70,000 patients have already received.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
12 Pandemic Dating Tips, How To Do Romance With The Covid-19 CoronavirusHere's how the Covid-19 coronavirus may change dating for the better:
Weiterlesen »
New COVID-19 Treatment Using Blood Plasma From Recovered Coronavirus Patients AuthorizedPresident Donald Trump has granted an emergency authorization of convalescent plasma as a treatment for COVID-19, according to a letter from the Food and Drug Administration. “We’ve bee…
Weiterlesen »
Will Trump Pressure the FDA to Approve an Unsafe Covid-19 Vaccine?The Food and Drug Administration authorized use of plasma to treat coronavirus patients — after the president alleged the “deep state, or whoever” is holding up Covid-19 treatments
Weiterlesen »
Trump to Give Emergency Authorization to COVID-19 TreatmentAfter expressing frustration at the slow pace of approval for coronavirus treatments, President Donald Trump was set to announce on Sunday the emergency authorization of convalescent plasma for COVID-19 patients.
Weiterlesen »